OTCMKTS:ATMS

Artemis Therapeutics (ATMS) Stock Price, News & Analysis

$0.04
0.00 (0.00%)
(As of 05/3/2024 ET)
Today's Range
$0.04
$0.04
50-Day Range
$0.04
$0.08
52-Week Range
$0.11
$5.00
Volume
N/A
Average Volume
2,942 shs
Market Capitalization
$4.48 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
ATMS stock logo

About Artemis Therapeutics Stock (OTCMKTS:ATMS)

Artemis Therapeutics, Inc. is a biopharmaceutical company. It develops new treatments for serious and life-threatening infections. It Includes cytomegalovirus and malaria. The company was founded on April 22, 1997 and was headquartered in New York, NY.

ATMS Stock Price History

ATMS Stock News Headlines

ITRM Iterum Therapeutics plc
Urgent Nvidia Warning
Could Steve Job's 'Final Prophecy' Make You Rich? Just before he died, Steve Jobs issued a "Final Prophecy" that's now coming true... and making some people rich. In one recent 90-day stretch, 50 companies related to Jobs' "Final Prophecy" soared by 100% or more. What was Steve Jobs' last big prediction, and how can you get in on it? Professor Joel Litman explains everything... including the surprising group of stocks moving higher, and his No. 1 favorite stock in this space.
Nasa reveals new spacesuit for Artemis moon landing
Artemis Therapeutics Inc. (ATMS)
Urgent Nvidia Warning
Could Steve Job's 'Final Prophecy' Make You Rich? Just before he died, Steve Jobs issued a "Final Prophecy" that's now coming true... and making some people rich. In one recent 90-day stretch, 50 companies related to Jobs' "Final Prophecy" soared by 100% or more. What was Steve Jobs' last big prediction, and how can you get in on it? Professor Joel Litman explains everything... including the surprising group of stocks moving higher, and his No. 1 favorite stock in this space.
Artemis Therapeutics Inc
Nasa’s Artemis 1 moon mission explained
See More Headlines
Receive ATMS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Artemis Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today
5/03/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Miscellaneous chemical products
Sub-Industry
N/A
Current Symbol
OTCMKTS:ATMS
Employees
1
Year Founded
N/A

Profitability

Net Income
$-1,360,000.00
Net Margins
-299.54%
Pretax Margin
-299.54%

Debt

Sales & Book Value

Annual Sales
$310,000.00
Book Value
($0.01) per share

Miscellaneous

Free Float
103,687,000
Market Cap
$4.48 million
Optionable
Not Optionable
Beta
-1.92
12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?

Get This Free Report

Key Executives

  • Shimon Citron
    Chief Executive Officer & Director
  • Haim Tabak
    Chief Operating Officer
  • David Dana
    Chief Financial Officer
  • Dana Wolf
    Chief Medical Officer

ATMS Stock Analysis - Frequently Asked Questions

How have ATMS shares performed in 2024?

Artemis Therapeutics' stock was trading at $0.0720 at the start of the year. Since then, ATMS stock has decreased by 44.4% and is now trading at $0.04.
View the best growth stocks for 2024 here
.

How do I buy shares of Artemis Therapeutics?

Shares of ATMS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:ATMS) was last updated on 5/3/2024 by MarketBeat.com Staff

From Our Partners